Brief Information of the Cell Line and Protein
Cell Line ID: CL000043 , U2OS
Synonyms
U-2 OS
U-2OS
U-2-OS
U2-OS
U20-S
U20S
2T
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0042
Protein ID: PT01780 , Sphingosine 1-phosphate receptor 5
Gene Name S1PR5
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID Q9H228
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000043  Protein ID: PT01780
 
Compound ID Compound Name Compound Formula
CP0848219
(R)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N,N-dimethylacetamide hydrochloride
   Show/Hide
C25H28ClN5O3
 1
1
EC50 = 12.9 nM
   TI
   LI
   LO
   TS
CP0883372
(R)-5-(3-(1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H24N4O3
 1
1
EC50 = 15.06 nM
   TI
   LI
   LO
   TS
CP0906147
(S)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N,N-dimethylacetamide
   Show/Hide
C25H27N5O3
 1
1
EC50 = 15.23 nM
   TI
   LI
   LO
   TS
CP0883375
(R)-5-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxy-benzonitrile hydrochloride
   Show/Hide
C21H21ClN4O2
 1
1
EC50 = 20.11 nM
   TI
   LI
   LO
   TS
CP0845580
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-hydroxyethanesulfonamide
   Show/Hide
C23H24N4O5S
 1
1
EC50 = 32.28 nM
   TI
   LI
   LO
   TS
CP0848223
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxyazetidine-1-carboxamide
   Show/Hide
C25H25N5O4
 1
1
EC50 = 39.8 nM
   TI
   LI
   LO
   TS
CP0871098
(S)-5-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C21H20N4O2
 1
1
EC50 = 44.55 nM
   TI
   LI
   LO
   TS
CP0906148
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-meth-oxyethanesulfonamide
   Show/Hide
C24H26N4O5S
 1
1
EC50 = 49.98 nM
   TI
   LI
   LO
   TS
CP0248629
Ozanimod
   Show/Hide
C23H24N4O3
 1
1
EC50 = 55.2 nM
   TI
   LI
   LO
   TS
CP0861107
(+/-)-4-(5-(3,4,diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C21H22N2O4
 1
1
EC50 = 56.81 nM
   TI
   LI
   LO
   TS
CP0861106
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-hydroxyethanesulfonamide
   Show/Hide
C23H24N4O5S
 1
1
EC50 = 57.11 nM
   TI
   LI
   LO
   TS
CP0873702
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxyazetidine-1-carboxamide
   Show/Hide
C25H25N5O4
 1
1
EC50 = 76.11 nM
   TI
   LI
   LO
   TS
CP0871095
(+/-)-2-((4-(5-(3,4,diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)amino)ethanol
   Show/Hide
C23H27N3O4
 1
1
EC50 = 135.94 nM
   TI
   LI
   LO
   TS
CP0845581
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-methoxyethanesulfonamide
   Show/Hide
C24H26N4O5S
 1
1
EC50 = 173.55 nM
   TI
   LI
   LO
   TS
CP0417506
(5R)-5-[5-chloro-2-fluoro-4-[5-[2-methyl-6-(2-methylpropyl)pyrimidin-4-yl]-1,2,4-oxadiazol-3-yl]phenoxy]-1-methylpiperidin-2-one
   Show/Hide
C23H25ClFN5O3
 1
1
EC50 = 215 nM
   TI
   LI
   LO
   TS
CP0380202
(5S)-5-[[2,4-dimethyl-6-[5-[2-methyl-6-(2-methylpropyl)pyridin-4-yl]-1,2,4-oxadiazol-3-yl]pyridin-3-yl]oxymethyl]pyrrolidin-2-one
   Show/Hide
C24H29N5O3
 1
1
EC50 = 340 nM
   TI
   LI
   LO
   TS
CP0425163
(5S)-5-[2-methyl-6-[5-[2-methyl-6-(propan-2-ylamino)pyridin-4-yl]-1,2,4-oxadiazol-3-yl]pyridin-3-yl]oxypiperidin-2-one
   Show/Hide
C22H26N6O3
 1
1
EC50 = 350 nM
   TI
   LI
   LO
   TS
CP0385091
(5R)-5-[2-fluoro-4-[5-[2-methyl-6-(2-methylpropyl)pyrimidin-4-yl]-1,2,4-oxadiazol-3-yl]phenoxy]piperidin-2-one
   Show/Hide
C22H24FN5O3
 1
1
EC50 = 360 nM
   TI
   LI
   LO
   TS